APA (7th ed.) Citation

Okamura, T., Hosoi, H., Matsufusa, T., Akagi, Y., Iwamoto, R., Kosako, H., . . . Sonoki, T. (2022). Tirabrutinib maintenance therapy for a patient with high-dose methotrexate-ineligible primary central nervous system lymphoma. Annals of Hematology, 101(6), 1379. https://doi.org/10.1007/s00277-021-04744-0

Chicago Style (17th ed.) Citation

Okamura, Tadashi, et al. "Tirabrutinib Maintenance Therapy for a Patient with High-dose Methotrexate-ineligible Primary Central Nervous System Lymphoma." Annals of Hematology 101, no. 6 (2022): 1379. https://doi.org/10.1007/s00277-021-04744-0.

MLA (9th ed.) Citation

Okamura, Tadashi, et al. "Tirabrutinib Maintenance Therapy for a Patient with High-dose Methotrexate-ineligible Primary Central Nervous System Lymphoma." Annals of Hematology, vol. 101, no. 6, 2022, p. 1379, https://doi.org/10.1007/s00277-021-04744-0.